Bayesian proteoform modeling improves protein quantification of global proteomic measurements

Area of Science:

• Proteomics
• Computational Biology
• Biostatistics

Background:

• Mass spectrometry enables high-throughput proteomic analysis, offering a systems view of protein expression.
• Accurate protein quantification from measured peptides is a computational challenge, especially with increased throughput.
• Existing methods often overlook protein variations like alternate splicing and post-translational modifications, limiting biomarker discovery power.

Purpose of the Study:

• To introduce the Bayesian Proteoform Quantification model (BP-Quant) for improved relative protein abundance estimation.
• To address the limitation of existing methods that ignore proteoform variations.
• To enhance statistical inference and downstream analyses for biomarker discovery.

Main Methods:

• Developed a Bayesian Proteoform Quantification model (BP-Quant).
• Utilizes statistically derived peptide signatures to identify peptides outside dominant patterns or with multiple overexpression patterns.
• Employs standard statistical hypotheses to identify peptides with similar statistical behavior for a protein.

Main Results:

• BP-Quant improves relative protein abundance estimates by accounting for proteoform variations.
• Achieved similar accuracy to state-of-the-art methods in proteoform identification.
• Demonstrated significantly better specificity in proteoform identification compared to existing methods.

Conclusions:

• BP-Quant offers a robust approach for protein quantification in proteomics.
• The model enhances specificity and accuracy in identifying proteoforms.
• BP-Quant provides a valuable tool for biomarker discovery and systems biology research.